startup M&A healthcare

Healthcare startup exit strategies have become increasingly complex as biotechnology innovation intersects with evolving regulatory frameworks, reimbursement models, and capital market expectations. Founders and investors must now align scientific milestones with commercialization readiness and regulatory positioning to achieve optimal exit outcomes. In the United States, where oversight from the FDA, CMS, and SEC shapes market … Read more